<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the clinical significant of antiendothelial cell antibodies (AECA) in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: With human umbilical vein endothelial cell as substrate cell, sera from 59 Behcet's disease patients were detected for the presence of AECA by using fixed cell-ELISA </plain></SENT>
<SENT sid="2" pm="."><plain>The associations of AECA to clinical disease activity were analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, Sera from other 70 systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (including 28 Takayasu <z:hpo ids='HP_0012089'>arteritis</z:hpo>, 20 Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>, 8 polyarteritis nodosa, 9 microscopic polyangiitis, 5 Churg-Strauss syndrome), 57 <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), 25 <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> and 85 healthy donors were screened for AECA </plain></SENT>
<SENT sid="4" pm="."><plain>The associations of AECA to clinical disease activity were analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The prevalence of AECA by human umbilical vein endothelial cell cell-ELISA was 47.5% in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with patients with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (4.0%) and <z:mpath ids='MPATH_458'>normal</z:mpath> group (1.2%), AECA were more frequently found in patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e>, other systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (68.6%) and SLE (45.7%) (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The positive result on <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> testing was more frequently found in AECA-positive patient with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>After the treatment, patients with active disease entering remission showed a decrease in both AECA titers and the mean level of ESR (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: AECA could be found more frequently in patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e>, associated closely with disease activity, which suggest that AECA may be used as an index in monitoring disease activity and effect of therapy in <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>But AECA could also be found in other systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and SLE </plain></SENT>
</text></document>